June 28, 2017
Date: Jun 28, 2017
Duration: 20 Min
Sponsored by Millipore Sigma
As a senior leader in pharmaceutical development and manufacturing, you know that keeping up-to-date on industry trends is critical to maintaining competitive edge. But do you know how to actively drive these trends and apply them to your manufacturing processes? Are you collaborating with the right stakeholders in order to expand your capabilities and bring your innovation strategy to life?
In this webinar series, three subject matter experts will share their perspective on the future of the industry and provide specific case examples that demonstrate how collaboration enables trends that are shaping the future pharmaceutical manufacturing landscape. The presenters will specifically explore trends like next generation bioprocessing and expansion into emerging markets and present strategies for successful implementation that will reduce costs and timelines and increase productivity.
April 26, 2017 – Now Available for On-Demand ViewingIn the first webinar “How Collaboration Enables Future Trends in Pharmaceutical Manufacturing”, Dr. Helge Berg shares how to harness the power of education and collaboration to enable process intensification and manufacturing flexibility while reducing risk and increasing speed-to-market.Specific points include: |
|---|
May 31, 2017 – Now Available for On-Demand ViewingIn this webinar, “Case study: Industry Collaboration Makes Next Generation Biopharmaceutical Processing a Reality,” Merrilee Whitney presents a concrete case study of a successful international industry and academia consortium consigned to develop a next generation downstream bioprocessing will be discussed.You will get insights into: |
June 28, 2017 – Now Available for On-Demand ViewingIn this webinar, “How Collaboration Fosters Growth and Minimizes Risk in Emerging Pharmaceutical Markets,” Dr. Bala Raghunath, MilliporeSigma’s leading expert on biopharmaceutical purification processes, shares various considerations biopharma companies should factor into their plans to manage risk while expanding their drug pipeline and geographical footprint into emerging markets.The presentation explores: |
Transcripts of these presentations are available in this Special Report.
You May Also Like
